José Cândido Caldeira Xavier-Júnior

José Cândido Caldeira Xavier-Júnior

Auto-generated profile, based on publicly available information

José Cândido Caldeira Xavier-Júnior

Instituto de Patologia de Araçatuba, Araçatuba, SP, Brazil; Faculty of Medicine, Centro Universitário Católico Unisalesiano, Araçatuba, SP, Brazil; Postgraduate Program in Pathology, Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
HPHeber Paulino Pena
Heber Paulino Pena
Vinícius Silva BeloVinícius Silva Belo
Vinícius Silva Belo
JXJosé Cândido Caldeira Xavier‐Junior
José Cândido Caldeira Xavier‐Junior
RTRafael Gonçalves Teixeira‐Neto
Rafael Gonçalves Teixeira‐Neto
SMSaulo Nascimento Melo
Saulo Nascimento Melo
ESEduardo Sérgio da Silva
Eduardo Sérgio da Silva
Objectives: To analyse the accuracy of American tegumentary leishmaniasis (ATL) diagnostic methods and evaluate the quality of the existing publications by means of a systematic review.Methods: Diagnostic tests evaluated in at least two studies with common reference standards were included in the sensitivity and/or specificity meta‐analyses. Quality and susceptibility to bias were analysed using the QUADAS‐2 and STARD tools.Results: The title and abstract of 3387 publications were evaluated after deduplication resulting from database searches. Thirty‐eight studies were included in the review, and 26 of them had results inserted in meta‐analyses. The diagnostic methods with the highest pooled sensitivity values were ELISA, polymerase chain reaction (PCR), indirect immunofluorescence reaction and Montenegro’s intradermal reaction. Cytometry was assessed in only two studies and presented 100% sensitivity in both. Smear slide microscopy and histopathology showed low pooled values of sensitivity. For specificity, the highest pooled values were identified for PCR. High values were also identified for ELISA, except for studies in which the reference standard for defining negative participants included individuals with Chagas’ disease or paracoccidioidomycosis, which also occurred for cytometry. IFR had lower specificities than ELISA. There was a predominance of case–control designs of phase 1 or 2 and only four studies were strongly recommended as evidence generators. Several reference standards were adopted, and different methods were assessed in a small number of studies.Conclusion: PCR showed the highest accuracy for the diagnosis of ATL, and its use should be encouraged in clinical practice. ELISA is recommended for the screening of suspected individuals, but the possibility of cross‐reactions should be considered. New validation studies for the tests evaluated in few publications and studies of phase 3 with appropriate methods are needed.

15 October 2024 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
MAMarcel Arakaki Asato
Marcel Arakaki Asato
FNFrancisco Alves Md Moraes Neto
Francisco Alves Md Moraes Neto
MMMarcelo Padovani de Toledo Moraes
Marcelo Padovani de Toledo Moraes
JOJuliana Polizel Ocanha-Xavier
Juliana Polizel Ocanha-Xavier
LTLuiz Carlos Takita
Luiz Carlos Takita
JXJosé Cândido Caldeira Xavier-Júnior
José Cândido Caldeira Xavier-Júnior
Cutaneous melanoma can lead to metastasis, and it is associated with high mortality. Currently, there are no widely accepted immunohistochemistry markers for melanoma prognosis in routine staging. Preferentially expressed antigen in melanoma (PRAME) is a possible biomarker for prognosis in several noncutaneous neoplasms. Ki-67 is a cell proliferation marker correlated with poor outcomes in many cancers. This study assessed PRAME and Ki-67 as potential prognostic markers for sentinel lymph node outcomes and survival among melanoma patients. This is a retrospective study analyzing cutaneous melanoma cases from a Brazilian cancer center (2005–2021). All cases were tested using immunohistochemistry to evaluate PRAME expression and Ki-67 index. Descriptive analysis, Spearman correlations, means comparison, Kaplan–Meier analysis, χ2, and Cox models were performed. In univariate analysis of 123 cutaneous melanoma cases, high extent (P = 0.0267) and elevated intensity (P = 0.043) of PRAME were associated with decreased overall survival. The Ki-67 index was associated with overall survival (P = 0.05) and sentinel lymph node status (P = 0.0403), with a positive correlation between the markers (P = 0.0004) and between Ki-67 and Breslow thickness (P = 0.0001). However, in multivariate analysis, only Breslow thickness significantly influenced overall survival (P = 0.0003). Then, the present results can suggest that elevated PRAME and Ki-67 expression are associated with poor overall survival in cutaneous melanoma; however, in multivariate analysis, only the Breslow thickness had a significant influence. These findings highlight the potential of PRAME and Ki-67 as prognostic markers, opening frontiers that could improve strategies for treating cutaneous melanoma.

1 January 2017 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
PDF file
JCJ. Andrew Carlson
J. Andrew Carlson
JXJose Candido Caldeira Xavier
Jose Candido Caldeira Xavier
ATAshley Tarasen
Ashley Tarasen
CSChristine E. Sheehan
Christine E. Sheehan
GOGeoff Otto
Geoff Otto
JRJeffrey S. Ross
Jeffrey S. Ross
Comprehensive genomic profiling of clinical samples by next-generation sequencing (NGS) can identify one or more therapy targets for the treatment of metastatic melanoma (MM) with a single diagnostic test. NGS was performed on hybridization-captured, adaptor ligation–based libraries using DNA extracted from 4 formalin-fixed paraffin-embedded sections cut at 10 microns from 30 MM cases. The exons of 182 cancer-related genes were fully sequenced using the Illumina HiSeq 2000 at an average sequencing depth of 1098X and evaluated for genomic alterations (GAs) including point mutations, insertions, deletions, copy number alterations, and select gene fusions/rearrangements. Clinically relevant GAs (CRGAs) were defined as those identifying commercially available targeted therapeutics or therapies in registered clinical trials. The 30 American Joint Committee on Cancer Stage IV MM included 17 (57%) male and 13 (43%) female patients with a mean age of 59.5 years (range 41–83 years). All MM samples had at least 1 GA, and an average of 2.7 GA/sample (range 1–7) was identified. The mean number of GA did not differ based on age or sex; however, on average, significantly more GAs were identified in amelanotic and poorly differentiated MM. GAs were most commonly identified in BRAF (12 cases, 40%), CDKN2A (6 cases, 20%), NF1 (8 cases, 26.7%), and NRAS (6 cases, 20%). CRGAs were identified in all patients, and represented 77% of the GA (64/83) detected. The median and mean CRGAs per tumor were 2 and 2.1, respectively (range 1–7). Comprehensive genomic profiling of MM, using a single diagnostic test, uncovers an unexpectedly high number of CRGA that would not be identified by standard of care testing. Moreover, NGS has the potential to influence therapy selection and can direct patients to enter relevant clinical trials evaluating promising targeted therapies.

23 February 2017 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
JXJosé Cândido Caldeira Xavier-Júnior
José Cândido Caldeira Xavier-Júnior
RDRozany Mucha Dufloth
Rozany Mucha Dufloth
DVDiama Bhadra Vale
Diama Bhadra Vale
MLMarcelo Tavares de Lima
Marcelo Tavares de Lima
LZLuiz Carlos Zeferino
Luiz Carlos Zeferino
Objective To evaluate the association of age at first sexual intercourse with the results of the cervicovaginal cytology. Study Design Observational analytical study about the prevalence of altered cervicovaginal cytology results in women aged between 18 and 34 years from a densely populated area in Brazil, during 10 years. The patients were stratified into 2 categories according to their age at first sexual intercourse (13–16 years and 17–24 years). Results From the total of 2,505,154 exams, 898,921 tests were in accordance with the inclusion criteria. Considering women with 4 years or less from the first sexual intercourse as a reference, those with 5 to 9 years and 10 years or more showed a higher prevalence of high-grade squamous intraepithelial lesions (HSILs). Women with an earlier onset of sexual intercourse (13–16 years) showed higher prevalence ratios for atypical squamous cells (ASC), low-grade squamous intraepithelial lesion (LSIL) and HSIL. The prevalence ratio for HSIL adjusted by age at diagnosis and by age at first sexual intercourse was higher only for women with an earlier onset of sexual intercourse. Conclusions The age of first sexual intercourse could be a variable that might qualify the selection among young women who are really at a higher risk for HSIL.

1 April 2014 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
JXJosé Cândido C. Xavier-Júnior
José Cândido C. Xavier-Júnior
RDRozany M. Dufloth
Rozany M. Dufloth
DVDiama Bhadra Vale
Diama Bhadra Vale
TTThalita A. Tavares
Thalita A. Tavares
LZLuiz C. Zeferino
Luiz C. Zeferino

23 October 2020 in Lupus
Verified
Journal Article
Closed access
PDF file
JOJuliana P Ocanha-Xavier
Juliana P Ocanha-Xavier
CCCamila O Cola-Senra
Camila O Cola-Senra
JXJose Candido C Xavier-Junior
Jose Candido C Xavier-Junior
Reticular erythematous mucinosis (REM) was first described 50 years ago, but only around 100 case reports in English have been published. Its relation with other inflammatory skin disorders is still being debated. We report a case of REM, including the clinical and histopathological findings. Also, a systematic review of 94 English-language reported cases is provided. The described criteria for clinical and histopathological diagnosis are highlighted in order to REM can be confidently diagnosed.